Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR-8203 in Advanced Solid Tumors
NCT07769242Phase 2Not yet recruiting
- Sponsor
- Beijing Suncadia Pharmaceuticals Co., Ltd.
- Start
- Sep 2026
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
A Phase 2 trial of SHR-8203 in solid tumor, sponsored by Beijing Suncadia Pharmaceuticals Co., Ltd.. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
SHR-8203
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07769242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07769242.